Results 221 to 230 of about 154,747 (344)
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
Multiphysics Measurement Method for Supercapacitors State of Health Determination. [PDF]
Doucet T +6 more
europepmc +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source
Automated cementing quality detection using a domain-specific, multi-scale convolutional neural network. [PDF]
Yang W, Sun S, He Y, Wu H.
europepmc +1 more source
Casing design. Our effort to improve it.
Hajime Nakamura, Tsuneta Nakamura
openalex +2 more sources
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard +5 more
wiley +1 more source
Resolving Steam Turbine Casing Thermal Management Challenges with a Dual Attentive Bi-GRU Soft Sensor for Transient Operation. [PDF]
Kruk-Gotzman S, Bzymek G, Kania K.
europepmc +1 more source
Application of the Flexbie Synthetic Casing Tape (Scotchrap) to Foot Disorders.
Jun Ueda +5 more
openalex +2 more sources
Screening for lung cancer: A systematic review of overdiagnosis and its implications
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz +12 more
wiley +1 more source

